Olfaction and cardiovascular risk: a connection yet to be explored
DOI:
https://doi.org/10.34631/sporl.3114Keywords:
Smell, cardiovascular diseaseAbstract
Introduction: Cardiovascular disease (CVD) is highly prevalent in the general population, especially in older age groups. Published studies associate loss of smell with comorbidities such as dyslipidemia, stroke, and heart failure. However, results are inconsistent, and the relationship between CVD and olfactory dysfunction remains unclear.Objective: To evaluate the correlation between loss of smell, cardiovascular risk factors (CVRFs), and overall cardiovascular risk (CVR).
Material and methods: A retrospective study design, recruiting patients aged 40 years and older, observed on our Olfaction Clinic at a tertiary hospital between 2016 and 2024. CVRFs (sex, age, systolic blood pressure, total and HDL cholesterol, weight, height, smoking habits, and the presence of diabetes mellitus (DM)) were assessed. The degree of loss of smell was quantified using the Burghart Sniffin' Sticks Identification Test (0-16). CVR was calculated using the SCORE2, SCORE2-OP (patients >70 years), and SCORE2-DM (diabetic patients). A case-control study and correlation analysis between the identification score and the other variables were performed. The control group included age- and sex-matched individuals with no subjective loss of smell. Statistical analysis was performed using SPSS® 30.0 for MacOs.
Results: 119 patients were included (81 with changed sense of smell and 38 in the control group). The mean age was 61 ± 11 years, 79 were female; 16.8% had diabetes. The study group had a mean olfactory identification score of 8.4 ± 4 and a mean CVR of 7.7% ± 6%.Our results showed that our patients with olfactory dysfunction have significantly higher total cholesterol levels and a greater tendency to DM (p = 0.054), although this was not statistically significant. When subgroup analysis was applied and patients with smell loss due to sinonasal pathology were excluded, a statistically significant relationship was found between smell identification results and CVR (p = 0.031), as well as with total cholesterol (p = 0.044). No other statistically significant associations were found in the other variables evaluated.
Conclusion: This is the first study to explore the relationship between CVR and smell disorders in the Brazilian population. This study suggests an association between smell loss, elevated serum cholesterol, and increased CVR.
Downloads
References
Roh D, Lee DH, Kim SW, Kim SW, Kim BG, Kim DH. et al. The association between olfactory dysfunction and cardiovascular disease and its risk factors in middle-aged and older adults. Sci Rep. 2021 Jan 13;11(1):1248. doi: 10.1038/s41598-020-80943-5.
Wehling E, Naess H, Wollschlaeger D, Hofstad H, Bramerson A, Bende M. et al. Olfactory dysfunction in chronic stroke patients. BMC Neurol. 2015 Oct 12:15:199. doi: 10.1186/s12883-015-0463-5.
Chamberlin KW, Yuan Y, Li C, Luo Z, Reeves M, Kucharska-Newton A. et al. Olfactory impairment and the risk of major adverse cardiovascular outcomes in older adults. J Am Heart Assoc. 2024 Jun 18;13(12):e033320. doi: 10.1161/JAHA.123.033320.
Liu G, Zong G, Doty RL, Sun Q. Prevalence and risk factors of taste and smell impairment in a nationwide representative sample of the US population: a cross-sectional study. BMJ Open. 2016 Nov 9;6(11):e013246. doi: 10.1136/bmjopen-2016-013246.
Task Force Members, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol. 2016 Jul;23(11):NP1-NP96. doi: 10.1177/2047487316653709
Desiato VM, Levy DA, Byun YJ, Nguyen SA, Soler ZM, Schlosser RJ. The prevalence of olfactory dysfunction in the general population: a systematic review and meta-analysis. Am J Rhinol Allergy. 2021 Mar;35(2):195-205. doi: 10.1177/1945892420946254.
Frasnelli J, Lundström JN, Boyle JA, Djordjevic J, Zatorre RJ, Jones-Gotman M. Neuroanatomical correlates of olfactory performance. Exp Brain Res. 2010 Feb;201(1):1-11. doi: 10.1007/s00221-009-1999-7.
Cardella A, Ferrulli A, Vujosevic S, Preti A, Ambrogi F, Terruzzi I. et al. Olfactory dysfunction in patients with type 2 diabetes mellitus. Rhinology. 2024 Oct 1;62(5):537-547. doi: 10.4193/Rhin23.451.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Carlota Sousa, Joana Guincho, Luís Baptista, Filipe Correia, Mariana Donato, Pedro Escada

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.